Two case studies demonstrate the difficulty, delay in recognizing this rare autoinflammatory disease
Search results for: FLARE
Atacicept, Mavrilimumab Drug Updates, Trials, Safety Data
Plus, rheumatology drug news, safety updates
Vaccinations for Immunocompromised Patients Are Shared Responsibility of Specialists, Primary Care Physicians
Infectious Diseases Society of America recommends both physician groups educate patients, household members on importance of vaccines
EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis
Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA
Coding Corner Question: August
Level 4 coding for a follow-up visit by a patient with gout
Rheumatology Drug Updates, Trials, Safety Data
An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid
Lupus Classification Criteria Expanded; Treat-to-Target Approach Gains Support
Rheumatologists at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco outline disease classification criteria, treat-to-target approach to lupus
Hospitalists Gain Insight on Signs, Symptoms of Infection Among Inpatients on Biologic Drugs
Rheumatologist at Society of Hospital Medicine conference provides treatment recommendations for hospital patients with rheumatic disease
Clinical Applications of Dual-Energy Computed Tomography for Rheumatology
Advanced imaging technique allows physicians to detect deposition of monosodium urate crystals not apparent in physical exams and better diagnose gout
Synthetic Hydrogel (aka Squishy Gel) Could Revolutionize Arthritis Treatment
Squishy gel could include a chemical compound capable of helping repair, restore or regenerate cartilage in a joint.
- « Previous Page
- 1
- …
- 56
- 57
- 58
- 59
- 60
- …
- 68
- Next Page »